(Total Views: 453)
Posted On: 05/20/2022 8:32:55 PM
Post# of 30035
$AMBS Q1 filed. Reg A updated filing in progress to help consummate the Cutanogen sale + debt extinguishment. MANF endothelial cell patent filing was a major development re COVID and Long COVID. Elto Pharma + MANF is the future for AMBS development programs
https://twitter.com/G_Commish/status/15278085...g&s=19
https://twitter.com/G_Commish/status/15278085...g&s=19
(1)
(0)Scroll down for more posts ▼
